Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) accounts for 90% of liver tumours and is one of the leading
causes of mortality. Cirrhosis due to viral hepatitis, alcohol or steatohepatitis is the major risk …

The Warburg effect is important for cancer cell proliferation. This phenomenon can be
flexible by interaction between glycolysis and mitochondrial oxidation for energy production …

Recently, treatments for unresectable hepatocellular carcinoma (HCC) have undergone
remarkable development. Various systemic chemotherapy drugs have been approved and …

Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local
control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been …

Background: Comparative outcomes of HBV-infected compensated cirrhosis with low-level
viremia (LLV) versus maintained virological response (MVR) are unclear. We conducted a …

Introduction: Prospective evidence supporting the safety and efficacy of carbon-ion
radiotherapy (C-ion RT) for hepatocellular carcinoma (HCC) remains lacking. This …

Purpose This systematic review and meta-analysis reports on outcomes and hepatic toxicity
rates following stereotactic body radiotherapy (SBRT) for liver confined hepatocellular …

It is unclear whether tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF) is
more effective for preventing hepatocellular carcinoma (HCC) development in patients with …

Methods We searched databases for randomized trials assessing the efficacy of loco-
regional treatments for HCCs≤ 5 cm with no extrahepatic spread or portal invasion. The …